Big Pharma Split Corp Class A has seen notable price action this week amid distribution announcements.
This week, Big Pharma Split Corp Class A (PRM.TO) experienced a price increase of 4.83%, closing at C$14.99. The stock's movement comes as Harvest Portfolios Group Inc. declared multiple monthly cash distributions for the upcoming years, which may have contributed to investor interest.
Advertisement
Big Pharma Split Corp Class A
PRM.TO
PRM.TO
Big Pharma Split Corp Class A
WealthAwesomeMarket cap
$19.68M
Div. yield
8.49%
Div. / share
$1.24
52W high
$15.89
52W low
$10.91
1W change
+4.83%
Beta
0.73
Analyst Price Targets
Based on analyst covering PRM · as of Sep 17, 2026
Wall Street analysts forecast PRM stock price to fall 86.7% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.00
-86.7% Upside
Current Price
C$14.99
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRM's historical volatility
30-Day Vol
32.0%
Annualized
90-Day Vol
31.1%
Annualized
Trend (90d)
+8.2%
Annualized drift
90d Mean
C$15.44
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$15.14 | C$13.56 – C$16.90 |
| 60 trading days | C$15.29 | C$13.08 – C$17.87 |
| 90 trading days | C$15.44 | C$12.75 – C$18.68 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While the recent distribution announcements may appeal to income-focused investors, the stock's overall technical indicators and analyst outlook suggest caution.
Big Pharma Split Corp Class A Closes at C$14.99 with 4.83% Weekly Gain
The stock's performance indicates a modest rise in interest, but overall trading volume remains low compared to its average.
Bull case
The announced distributions could attract income-seeking investors, which might help stabilize the stock's performance in the short term. This could provide a reliable income stream for shareholders, making the stock more appealing.
Bear case
However, there’s a significant gap between the current trading price and analyst targets, along with a bearish outlook that poses risks for potential investors. This discrepancy suggests that the stock may face challenges ahead, which could impact its attractiveness.
Recent Price Action
Big Pharma Split Corp Class A closed at C$14.99 on Wednesday, reflecting a 2.88% increase for the day and a notable 4.83% gain over the week. This upward movement may be attributed to recent announcements regarding monthly cash distributions by Harvest Portfolios.
Catalysts Behind the Move
Advertisement
The recent announcements by Harvest Portfolios Group regarding monthly cash distributions of C$0.1031 per Class A share for several months in 2026 could be driving interest in Big Pharma Split Corp. These distributions are set to be paid out in October 2026, September 2026, and earlier months, providing a steady income stream for shareholders.
Technical Picture
Currently, Big Pharma Split Corp Class A is trading above its 50-day moving average of C$14.89, indicating a bullish short-term trend. The 200-day moving average stands at C$14.29, suggesting a longer-term positive outlook as well. The stock has a 52-week range of C$10.91 to C$15.89, currently sitting at approximately 82% of its range. However, the stock's beta of 0.73 indicates lower volatility compared to the market.
Volume Analysis
The latest trading volume for Big Pharma Split Corp Class A was only 11 shares, significantly lower than the 20-day average volume of 1,601 shares. This low volume indicates a lack of strong investor interest, which could impact the stock's price stability in the near term.
Price Action Summary
As of the latest close, Big Pharma Split Corp Class A is trading at C$14.99, reflecting a 1-day increase of 2.88%. While the recent distribution announcements may provide some support, the overall low trading volume and bearish analyst outlook suggest that investors should proceed with caution.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
